Angiex
Developer of vascular-targeted biotherapeutics designed for the treatment of solid cancers and other diseases of pathological angiogenesis. The company's antibody-drug conjugate therapy for solid canc...
Valuation
$0
Share Price
N/A
Total Raised
$98.7M
Last Round
Unknown
Latest Funding Round
Unknown
Investors
+18 other investors